organ transplant Oncocyte Q1 Revenues Rise 27 Percent on DetermaRx Activity The Irvine, California-based diagnostics firm reported $1.4 million in revenue, missing the consensus Wall Street estimate of $2.2 million. Hologic Nabs FDA Approval for Quantitative Cytomegalovirus Test The test runs on Hologic's Panther system and is intended to be used for post-transplant pathogen detection and monitoring. Natera Adds Clinical Utility Evidence for Cell-Free DNA in Allograft Health Premium Three new studies focusing on the heart, lungs, and kidneys add to a growing body of evidence in support of donor-derived cell-free DNA as an organ health measure. Post-Transplant Diabetes Risk Informed by Polygenic Risk Profiles in Donors, Recipients Along with insights from recipient risk scores, researchers found that liver donors' type 2 diabetes PRS was associated with post-transplant diabetes mellitus in recipients. CareDx to Study AlloSure Kidney for Routine Organ Transplant Surveillance in Pediatric Patients The company is teaming up with the North American Pediatric Renal Trials and Collaborative Studies organization to study the long-term impact of AlloSure. Nov 24, 2021 NGeneBio Gets CE-IVD Mark for HLA Typing Assay Nov 5, 2021 Natera Aiming to Translate Success in Colorectal Cancer Diagnostics Into Other Areas Premium Nov 5, 2021 Genome Diagnostics Makes €1M Investment in CRISPR Diagnostics Startup Scope Biosciences Oct 29, 2021 CareDx Works Toward Goal of Becoming Essential Transplant Diagnostics Company Premium Sep 29, 2021 CareDx Patents Deemed Invalid in Court Battle Against Natera, Eurofins Viracor Jul 13, 2021 Natera Inks Distribution Deal With TomaLab for Italy Apr 22, 2021 Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection Mar 17, 2021 CareDx Acquires European Transplant Surveillance Software Firm BFS Molecular Feb 25, 2021 CareDx Expanding Diagnostic Tech Into Cell Transplant Monitoring Premium Feb 24, 2021 CareDx Q4 Revenues Up 64 Percent Feb 11, 2021 Roche Receives FDA Clearance for Cobas BKV Test for Use With Urine Samples Feb 8, 2021 Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test Jan 27, 2021 Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy Premium Jan 21, 2021 CareDx Prices $175M Common Stock Offering Jan 13, 2021 At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Jan 11, 2021 CareDx Preliminary Q4 Revenues Up 63 Percent, Beat Estimates Jan 7, 2021 CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Nov 6, 2020 Natera Expects Further Growth in NIPT as it Expands Use Cases for Cancer, Transplant Tests Premium Nov 5, 2020 Natera Q3 Revenues Up 26 Percent on Increased Testing Volumes Load More Breaking News Mitochondrial Protein Resource Reveals New Disease Players StageZero Life Sciences, DiagnoseAtHome Partner on Multicancer Blood Test OraSure Technologies Selected by HHS to Provide COVID-19 School Testing Hologic Obtains CE Mark for Molecular Epstein-Barr, BK Virus Assays Multiomics Startup Pleno Closes $15M Funding Round SeekIn Gets CE Mark for Cancer Treatment Response Monitoring Kit The Scan UK Moves to Allow Sale of Gene-Edited Food The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist. Questions for the Field Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do. Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more. Taking Stock of the Stockpile The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.